期刊文献+

脂蛋白(a)与其他脂蛋白和载脂蛋白相关性研究 被引量:2

Study on the correlation of lipoprotein(a)with other serum lipoproteins and apolipoproteins
下载PDF
导出
摘要 目的探讨冠心病患者血浆脂蛋白(a)与HDL-C、LDL-C、载脂蛋白(apo)A-Ⅰ、apoB的相关性,评价血脂异常与冠心病的相关性。方法选择因胸痛入院的患者1011例,经冠状动脉造影确诊为冠心病患者613例作为冠心病组,非冠心病患者398例作为对照组。测定脂蛋白(a)、apoA-Ⅰ、apoB、HDL-C和LDL-C,进行相关性分析,并计算apoB/apoA-Ⅰ比值。结果冠心病组的脂蛋白(a)、LDL-C及apoB水平较对照组明显升高(P=0.000);冠心病组脂蛋白(a)水平与LDL-C、apoB呈显著正相关(r=0.135、r=0.168,P<0.01),与HDL-C、apoA-Ⅰ无相关性。对照组脂蛋白(a)与LDL-C、apoB呈显著正相关(r=0.201、r=0.236,P<0.01),与HDL-C、apoA-Ⅰ无相关性。apoB/apoA-Ⅰ是诊断冠心病最显著的独立危险因素(OR=31.577,95% CI:8.324~11 9.788,P=0.000),其次为脂蛋白(a)(OR=19.446,95% CI:3.831~98.716,P=0.000)。结论脂蛋白(a)与LDL-C、apoB呈正相关,提示三者均为动脉粥样硬化的危险因素;apoB/apoA-Ⅰ和脂蛋白(a)为冠心病的独立危险因素。 Objective To explore the correlation between lipoprotein(a)[Lp(a)] and other lipo protein-related parameters including HDL-C, LDL-C,apoA-I and apoB,and to evaluate the relationship of dyslipidemia with coronary artery disease(CAD). Methods 1011 patients who had complained chest pain were selected to receive the coronary angiography in our department. Of them,613 cases were confirmed to have coronary artery disease(CAD group) ,and other 398 cases without CAD served as a control group. All patients underwent individual detection of Lp(a), apoA-I and apoB by means of immunoturbidimetry method,and of HDL-C and LDL-C by enzy- matic approach. The correlation analysis was carried out, and the apoB/apoA- I ratio was calcu- lated. Results The levels of Lp(a) ,LDL-C and apoB were significantly higher in CAD group than in control group (P = 0.000). In CAD group,Lp(a) was demonstrated to have a positive correlation with LDL-C and apoB (r = 0. 135,r = 0. 168,P 〈 0.01). In control group,Lp(a) was also demonstrated to have a positive correlation with LDL-C and apoB (r = 0. 201,r = 0. 236,P〈 0.01).Both apoB/apoA-I (OR = 31. 577,95% CI. 8. 324-119. 788, P = 0.000) and Lp(a) (OR= 19. 446,95% CI. 3. 831-98. 716, P = 0. 000) were independent risk factors for diagnosing CAD. Conclusion The results indicate that in both groups,Lp(a) has a positive correlation with LDL-C and apoB,suggesting that all the three lipoproteins are risk factors for the atherosclerosis;apoB/apoA- I and Lp(a) are independent risk factors for coronary artery disease.
作者 王冠 李艳芳
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2010年第9期792-794,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 脂蛋白(A) 胆固醇 HDL 脂蛋白类 LDL 载脂蛋白类 血脂异常 冠心痛 冠状血管造影术 危险因素 lipoprotein (a) cholesterol, HDL lipoproteins, LDL apolipoproteins dyslipidemias coronary disease coronary angiography risk factors
  • 相关文献

参考文献9

  • 1Mcqueen M J,Hawken S,Wang X,et al.Lipids,lipoproteins,and apolipoproteins as risk markers of myocardial infarction in52 countries(the INTER HEART study):a case-control study.Lancet,2008,372:224-233.
  • 2Erqou S,Kaptoge S,Perry P L,et al.Lipoprotein(a)concentration and the risk of coronary heart disease,stroke,and nonvascular mortality.JAMA,2009,302:412-423.Erqou S,Kaptoge S,Perry P L,et al.Lipoprotein(a)concentration and the risk of coronary heart disease,stroke,and nonvascular mortality.JAMA,2009,302:412-423.
  • 3Nakano T,Nakajima K,Niimi M,et al.Detection of apolipoproteins B-48 and D-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases.Clin Chim Acta,2008,390:38-43.
  • 4Zlatohlavek L,Zidkova K,Vrablik M,et al.Lipoprotein(a)and its position among other risk factors of atherosclerosis.Physiol Res,2008,57:777-783.
  • 5Kamstrup PR,Tybjaerg-Hansen A,Steffensen R,et al.Genetically elevated lipoprotein(a)and increased risk of myocardial infarction.JAMA,2009,301:2331-2339.
  • 6Gomez M,Valle V,Aros F,et al.Oxidized LDL,lipoprotein(a)and other emergent risk factors in acute myocardial infarction(FORTIAM study).Rev Esp Cardiol,2009,62:373-382.
  • 7Qiu G,Hill JS.Endothelial lipase promotes apolipoprotein AI-mediated cholesterol efflux in THP-1 macrophages.Arterioscler Thromb Vasc Biol,2009,29:84-91.
  • 8Borberg H.Comparison of different Lp(a)elimination techniques:a retrospective evaluation.Transfus Apher Sci,2009,41:61-65.
  • 9Xiao C,Watanabe T,Zhang Y,et al.Enhanced cellular uptake of remnant high-density lipoprotein particles:a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.Circ Res,2008,103:159-166.

同被引文献26

  • 1Walldius G, Jungner I. The apoB/apoA-I ratio: A strong, new risk factor for cardiovascular disease and a target for lipid-lowering thera- py - A review of the evidence[J]. J Intern Med, 2006, 259 (5) : 493-519.
  • 2Camevale Schianea GP, Pedrazzoli R, Onolfo S, et al. ApoB/apoA I ratio is better than LDLC in detecting cardiovascular risk[ J]. Nutr Metab Cardiovas Dis, 2011, 21 (6) : 406-411.
  • 3Mughal MM, Khan MK, Demarco JK, et al. Symptomatic and a- symptomatic carotid artery plaque[ J]. Expert Rev Cardiovas Ther, 2011, 9 (10) : 1 315-330.
  • 4MarineUo E, Setacei C, Giubbolini M, et al. Lipid composition in atheromatous plaque: Evaluation of the lipid three-phase percent- age[J]. Life Sci, 2003, 72 (24) : 2 689-694.
  • 5Smith Jr. SC, Bonow RO, Hutter Jr. AM. AHA/ACC guidelines for secondary prevention for patients with coronary and other athero- sclerotic vascular disease: 2006 update [ J]. Circulation, 2006 , 113 (22): e847.
  • 6Vaverkova H. LDLC or apoB as the best target for reducing coro- nary heart disease: Should apoB be implemented into clinical prac- tice[J] ? Clinical Lipidology, 2011, 6 ( 1 ) : 35-48.
  • 7Davidson MH, Toth PP. High-density lipoprotein metabolism: po- tential therapeutic targets [ J ]. Am J Cardiol, 2007, 100 (11 SUP- PL. 1 ) : $32-$40.
  • 8Barter PJ, Rye KA. The rationale for using apoA-I as a clinical marker of cardiovascular risk[ J]. J Intern Med, 2006, 259 i5 ) : 447 -454.
  • 9陶洪夏.冠心病患者脂蛋白(a)测定及临床意义[J].中国临床保健杂志,2007,10(5):510-510. 被引量:5
  • 10Emerging risk factors collaboration, Erqou S, Kaptoge S, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke and nonvascular mortality [ J ]. JA- MA ,2009,302 (4) :412-423.

引证文献2

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部